Skip to main content
. 2018 Oct 30;10(11):593. doi: 10.3390/v10110593

Figure 2.

Figure 2

In vitro systems and screening approaches used for antiviral compound development against ZIKV. The text highlighted in green and red indicates advantages and limitations, respectively. PSCs: pluripotent stem cells, HTS: high-throughput screening, VYR: virus yield reduction, CPE: cytopathic effect.